Skip to main content

David Mott

Equibles does not estimate personal net worth.

About David Mott

David Mott is recorded as Board Member at Ardelyx, Inc. (ARDX) since June 18, 2025. Ardelyx, Inc. reported in an 8-K filed June 18, 2025 that David Mott was appointed Class II Director, effective June 18, 2025. Ardelyx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ardelyx, Inc. includes Michael Raab (CEO and Board Member), Keith Santorelli (CFO), Susan Hohenleitner (CFO) and 7 others.

“The Company's stockholders elected the Class II director nominees below to the Company's Board to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected.”
Ardelyx, Inc. Form 8-K, filed June 18, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-06-18–present

Leadership on record at Ardelyx, Inc.

Recent activity